Alain J. Cohen - 04 Jan 2022 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Issuer symbol
CCCC
Transactions as of
04 Jan 2022
Net transactions value
+$10,042
Form type
4
Filing time
18 Jan 2022, 15:30:26 UTC
Previous filing
05 Oct 2021
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Award $10,042 +318 +143% $31.58 540 04 Jan 2022 Direct F1, F2
holding CCCC Common Stock 1,804,324 04 Jan 2022 By Alain J. Cohen Revocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 4, 2022.
F3 Shares held by the Reporting Person as trustee of the Alain J. Cohen Revocable Trust.